DiaMedica Therapeutics, Inc. (DMAC)
6.85
+0.23
(+3.47%)
USD |
NASDAQ |
Apr 17, 16:00
6.845
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Market Cap : 369.10M for April 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 122.53B |
| IN8bio, Inc. | 6.537M |
| Calidi Biotherapeutics, Inc. | 2.996M |
| ACADIA Pharmaceuticals, Inc. | 3.780B |
| Alnylam Pharmaceuticals, Inc. | 41.07B |
Market Cap Related Metrics
| PEG Ratio | -0.6088 |
| Price to Book Value | 6.578 |
| Price | 6.85 |
| Earnings Yield | -10.19% |
| PEGY Ratio | -0.6088 |